ON-DEMAND WEBINAR

3 Major Disruptions to Clinical Trials in 2023

Who will be the winners and losers?

Clinical trial services have adapted to post-pandemic reality with accelerated innovation in trial approaches, virtual technologies and decentralization. What can we expect this year and what will the implications be?
 

Watch this on-demand webinar to find out! 

Chris Baker, President at ICON, Symphony Health and Jon Shephard, Partner at PwC, Deals & Strategy, share their insights based on years of experience working with and advising investors and the largest players in the industry.

What’s on the agenda?

  • Major disruptions to Clinical trials services in 2023
  • Implications, challenges and opportunities for investors and CROs
  • Who will benefit and who will miss out? 

Who will you hear from?  

Untitled design (11)-modified

Chris Baker

President at ICON, Symphony Health and former Executive VP and Global Head of Parexel FSP

Jonathan Shephard-modified

Jonathan Shephard

Partner at PwC, Deals and Strategy, Life Sciences

Why should you watch?  

Our speakers have extensive experience working with the world's largest CRO companies and advising clinical trials investors on all aspects of strategy, M&A, and due diligence. Drawing from their deep expertise, Chris and Jon will help you: 

  • Understand upcoming challenges and opportunities in the industry
  • Learn what types of companies are going to benefit and who will miss out
  • Get actionable advice on strategy and value optimisation

web elementos

About us

Fewer Calls. Better Insights. Faster

Arbolus is the go-to expert network for Investors and Consultants seeking a forward-thinking way to gain an information advantage.

Enabled by our tech-driven approach, we deliver better insights, from the best experts, in less time with innovative products, the most relevant, hard-to-find experts and a dedicated team you can rely on.